Literature DB >> 9121492

Identification of growth hormone receptor (GHR) tyrosine residues required for GHR phosphorylation and JAK2 and STAT5 activation.

X Wang1, C J Darus, B C Xu, J J Kopchick.   

Abstract

To determine whether GH receptor (GHR) cytoplasmic tyrosine residue(s) and tyrosine phosphorylation are required for signal transduction, we have substituted the eight porcine (p) GHR cytoplasmic tyrosines with phenylalanine individually or in a stepwise manner from the C terminus. Conversely, the eight tyrosines were individually regenerated in a non-tyrosine-containing pGHR analog. Mutated pGHR cDNAs were transfected into mouse L cells (MLCs) and cell lines were established. Each individual tyrosine-substituted pGHR analogs was able to activate STAT5 (signal transducer and activator of transcription 5; previously termed pp95) at levels comparable to those of wild type pGHR. Analyses of these pGHR analogs revealed that a single tyrosine residue at position 487, 534, 566, or 627 is sufficient for STAT5 phosphorylation. This result suggested that a redundancy in tyrosine residue requirement may be employed in GH-mediated signal transduction. Also, we found that the requirement of tyrosine residues for STAT5 phosphorylation directly correlated with their phosphorylation status. Combining both STAT5 and GHR tyrosine phosphorylation results, we have deduced that Y332, Y487, Y534, Y566, and Y627 are pGHR tyrosine phosphorylation sites. Additionally, Janus kinase 2 was activated by GH in all pGHR tyrosine-substituted analogs, including one containing no intracellular tyrosines, which agrees with a previous report that Janus kinase 2 activation is independent of GHR tyrosine phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9121492     DOI: 10.1210/mend.10.10.9121492

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  22 in total

Review 1.  Pegvisomant: a growth hormone receptor antagonist used in the treatment of acromegaly.

Authors:  Nicholas A Tritos; Beverly M K Biller
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

2.  Fos-Zippered GH Receptor Cytosolic Tails Act as Jak2 Substrates and Signal Transducers.

Authors:  Tobias Nespital; Lieke M van der Velden; Anneloes Mensinga; Elisabeth D van der Vaart; Ger J Strous
Journal:  Mol Endocrinol       Date:  2016-02-09

3.  Growth hormone-induced JAK2 signaling and GH receptor down-regulation: role of GH receptor intracellular domain tyrosine residues.

Authors:  Luqin Deng; Jing Jiang; Stuart J Frank
Journal:  Endocrinology       Date:  2012-03-13       Impact factor: 4.736

4.  Stoichiometric structure-function analysis of the prolactin receptor signaling domain by receptor chimeras.

Authors:  W P Chang; Y Ye; C V Clevenger
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

5.  Dwarfism and increased adiposity in the gh1 mutant zebrafish vizzini.

Authors:  Sarah K McMenamin; James E N Minchin; Tiffany N Gordon; John F Rawls; David M Parichy
Journal:  Endocrinology       Date:  2013-03-01       Impact factor: 4.736

Review 6.  Modulation of growth hormone receptor abundance and function: roles for the ubiquitin-proteasome system.

Authors:  Stuart J Frank; Serge Y Fuchs
Journal:  Biochim Biophys Acta       Date:  2008-06-09

7.  Autophosphorylation of JAK2 on tyrosines 221 and 570 regulates its activity.

Authors:  Lawrence S Argetsinger; Jean-Louis K Kouadio; Hanno Steen; Allan Stensballe; Ole N Jensen; Christin Carter-Su
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

Review 8.  Mechanistic aspects of crosstalk between GH and PRL and ErbB receptor family signaling.

Authors:  Stuart J Frank
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-31       Impact factor: 2.673

9.  Central and peripheral actions of somatostatin on the growth hormone-IGF-I axis.

Authors:  Robert D Murray; Kiwon Kim; Song-Guang Ren; Marjorie Chelly; Yutaka Umehara; Shlomo Melmed
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

10.  Human GH receptor-IGF-1 receptor interaction: implications for GH signaling.

Authors:  Yujun Gan; Ashiya Buckels; Ying Liu; Yue Zhang; Andrew J Paterson; Jing Jiang; Kurt R Zinn; Stuart J Frank
Journal:  Mol Endocrinol       Date:  2014-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.